Noramco Buprenorphine Hydrochloride Noramco Buprenorphine Hydrochloride

X

List of Japan Drug Master File (JDMF) for Buprenorphine Hydrochloride Active Pharmaceutical Ingredient submitted to the Review Authority in Japan (PMDA) and listed on PharmaCompass.com

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

Flag U.S.A
Digital Content Digital Content
218MF11027
10 Wheatfield Road, Edinburgh EH11 ...
2013-11-11
2006-12-28
Flag India
Digital Content Digital Content
URL Supplier Web Content
231MF10001
206, Eric House, 16th Road, Chembur...
2019-01-10
2019-01-10
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
left grey arrow
right gray arrow
  • INJECTABLE;INJECTION - EQ 0.3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • IMPLANT;IMPLANTATION - EQ 80MG BASE/IMPLANT
  • FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE
  • FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE
  • FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE
  • TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • FILM;BUCCAL - EQ 0.075MG BASE
  • FILM;BUCCAL - EQ 0.15MG BASE
  • FILM;BUCCAL - EQ 0.3MG BASE
  • FILM;BUCCAL - EQ 0.45MG BASE
  • FILM;BUCCAL - EQ 0.6MG BASE
  • FILM;BUCCAL - EQ 0.75MG BASE
  • FILM;BUCCAL - EQ 0.9MG BASE
  • FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE
  • FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE
  • FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE
  • FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

Looking for 53152-21-9 / Buprenorphine Hydrochloride API manufacturers, exporters & distributors?

Buprenorphine Hydrochloride manufacturers, exporters & distributors 1

88

PharmaCompass offers a list of Buprenorphine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Buprenorphine Hydrochloride manufacturer or Buprenorphine Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Buprenorphine Hydrochloride manufacturer or Buprenorphine Hydrochloride supplier.

PharmaCompass also assists you with knowing the Buprenorphine Hydrochloride API Price utilized in the formulation of products. Buprenorphine Hydrochloride API Price is not always fixed or binding as the Buprenorphine Hydrochloride Price is obtained through a variety of data sources. The Buprenorphine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Buprenorphine Hydrochloride

Synonyms

Ncgc00247733-01, Dsstox_cid_28831, Dsstox_rid_83100, Dsstox_gsid_48905, Tox21_112899, Cas-53152-21-9

Cas Number

53152-21-9

About Buprenorphine Hydrochloride

A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.

Buprenorphine Hydrochloride Manufacturers

A Buprenorphine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Buprenorphine Hydrochloride, including repackagers and relabelers. The FDA regulates Buprenorphine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Buprenorphine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Buprenorphine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Buprenorphine Hydrochloride Suppliers

A Buprenorphine Hydrochloride supplier is an individual or a company that provides Buprenorphine Hydrochloride active pharmaceutical ingredient (API) or Buprenorphine Hydrochloride finished formulations upon request. The Buprenorphine Hydrochloride suppliers may include Buprenorphine Hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Buprenorphine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Buprenorphine Hydrochloride JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Buprenorphine Hydrochloride Drug Master File in Japan (Buprenorphine Hydrochloride JDMF) empowers Buprenorphine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Buprenorphine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Buprenorphine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Buprenorphine Hydrochloride suppliers with JDMF on PharmaCompass.

Buprenorphine Hydrochloride Manufacturers | Traders | Suppliers

Buprenorphine Hydrochloride Manufacturers, Traders, Suppliers 1
17

We have 2 companies offering Buprenorphine Hydrochloride

Get in contact with the supplier of your choice:

  1. Veranova
  2. Pioneer Agro Extracts
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY